Gongwin Biopharm Holdings Co Ltd
TPEX:6617
तय करें कि किस कीमत पर खरीदना आपके लिए उचित होगा। तैयार रहने में हम आपकी मदद करेंगे।
|
G
|
Gongwin Biopharm Holdings Co Ltd
TPEX:6617
|
TW |
|
N
|
Nsys Co Ltd
KOSDAQ:333620
|
KR |
|
C
|
CardioComm Solutions Inc
XTSX:EKG
|
CA |
|
I
|
IMPACT Growth Real Estate Investment Trust
SET:IMPACT
|
TH |
|
Rheinmetall AG
F:RHM
|
DE |
|
Rheinmetall AG
OTC:RNMBF
|
DE |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
E
|
Ecoplastic Corp
KOSDAQ:038110
|
KR |
|
I
|
Istyle Inc
F:IY5
|
JP |
|
AVAX One Technology Ltd
NASDAQ:AVX
|
CA |
|
L
|
Lamar Advertising Co
DUS:6LA
|
US |
|
W
|
Weir Group PLC
OTC:WEGRY
|
UK |
|
AMTD IDEA Group
F:9AM1
|
FR |
|
Fathom Holdings Inc
NASDAQ:FTHM
|
US |
|
Chimera Investment Corp
NYSE:CIM
|
US |
|
S
|
Steelcase Inc
F:GJB
|
US |
|
P
|
Publicis Groupe SA
DUS:PU4
|
FR |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
NetEase Inc
NASDAQ:NTES
|
CN |
|
Kingfa Science and Technology (India) Ltd
NSE:KINGFA
|
IN |
|
H
|
Huangshan Novel Co Ltd
SZSE:002014
|
CN |
|
S
|
Steelcase Inc
SWB:GJB
|
US |
|
Kerry Group PLC
ISEQ:KRZ
|
IE |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
आंतरिक मूल्य
Gongwin Biopharm Holdings Co Ltd का आंतरिक मूल्य भरोसेमंद ढंग से निकालने के लिए पर्याप्त डेटा नहीं है।
क्या हमारे मूल्यांकन वास्तव में कारगर हैं? बैकटेस्ट के परिणाम देखें .
मौलिक विश्लेषण
Gongwin Biopharm क्या करती है
Gongwin Biopharm Holdings Co., Ltd. engages in the operation of Minimally Invasive Targeted Tumor Ablation business. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-02-08. The Company’s headquarter is located in Taiwan and it created a cross-regional platform composed of Taiwan, China Mainland and the United States. The new PTS drug researched and developed by the Company is a new drug product for cancer treatment combined with minimally invasive interventional therapy technology, including PTS100 for the treatment of liver cancer, PTS302 for the treatment…
- मुख्यालय
- ताइवान TW
- IPO की तारीख
- फ़र. 8, 2017
